Liver Diseases  >>  oltipraz (PMK-N01GI1)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oltipraz (PMK-N01GI1) / Canopus BioPharma, Pharmaking
NCT01373554: Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease

Completed
2
60
RoW
Placebo, Oltipraz
PharmaKing
Non-alcoholic Fatty Liver Disease
06/13
10/13

Download Options